PreSat
PreSat [NASA]
The PreSat (PharmaSat Risk Evaluation Satellite) CubeSat technology demonstration nanosatellite is a risk reduction and technology demonstration mission. It was developed in only 180 days in NASA Ames Research Center (ARC) Free Flyer (µSat FF) program, that is focused on implementing peer-reviewed fundamental space biology investigations on a microsatellite free flyer platform. It serves as a risk-reduction mission for PharmaSat.
The objectives of the mission are:
- Demonstrate / validate Performance of NASA-Ames 2nd Generation Modular Triple CubeSat Nanosatellite Platform
- Spaceflight Performance Evaluation of Generic BioFluidic Sample Management and Handling Subsystem using Optical Detection
- Evaluation of Payload Environmental Management Subsystem
The satellite failed to reach orbit due to a launch vehicle staging malfunction.
| Nation: | USA |
|---|---|
| Type / Application: | Technology |
| Operator: | NASA Ames Research Center |
| Contractors: | NASA Ames Research Center |
| Equipment: | |
| Configuration: | CubeSat (3U) |
| Propulsion: | None |
| Power: | Solar cells, batteries |
| Lifetime: | 60 days |
| Mass: | 4 kg |
| Orbit: | 330 km × 685 km, 9° |
| Satellite | Date | LS | Launch Vehicle | Remarks | |
|---|---|---|---|---|---|
| PreSat | 03.08.2008 | Om | F | Falcon-1 | with Trailblazer, Nanosail D, Celestis 07 |
